arrow
Back
R

Richard Kefford

Melanoma Institute Australia

125H-index
613Paper Count
10.4WCitation Count
Published Papers 155
Publication Date
IFN-y Signaling Sensitizes Melanoma Cells to BH3 Mimetics
err2023-07-01
err1
PREAI
errMing, Zizhen; Lim, Su Yin; Stewart, Ashleigh; Pedersen, Bernadette; Shklovskaya, Elena; Menzies, Alexander M.; Carlino, Matteo S.; Kefford, Richard F.; Lee, Jenny H.; Scolyer, Richard A.; V. Long, Georgina; Rizos, Helen
errShare
errSave
First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies
err2021-02-16
err21
PREAI
errPiha-Paul, Sarina A.; Thein, Kyaw Z.; De Souza, Paul; Kefford, Richard; Gangadhar, Tara; Smith, Christopher; Schuster, Shelly; Zamboni, William C.; Dees, Claire E.; Markman, Ben
errShare
errSave
Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia
err2021-01-01
err16
PREAI
errHong, Angela M.; Waldstein, Cora; Shivalingam, Brindha; Carlino, Matteo S.; Atkinson, Victoria; Kefford, Richard F.; McArthur, Grant A.; Menzies, Alexander M.; Thompson, John F.; Long, Georgina, V
errShare
errSave
Selective Oral MEK1/2 Inhibitor Pimasertib in Metastatic Melanoma: Antitumor Activity in a Phase I, Dose-Escalation Trial
err2020-11-19
err10
PREAI
errLebbe, Celeste; Italiano, Antoine; Houede, Nadine; Awada, Ahmad; Aftimos, Philippe; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Raymond, Eric; Faivre, Sandrine; Pages, Celine; Gomez-Roca, Carlos; Schueler, Armin; Goodstal, Samantha; Massimini, Giorgio; Delord, Jean-Pierre
errShare
errSave
Selective Oral MEK1/2 Inhibitor Pimasertib: A Phase I Trial in Patients with Advanced Solid Tumors
err2020-11-10
err7
PREAI
errDelord, Jean-Pierre; Italiano, Antoine; Awada, Ahmad; Aftimos, Philippe; Houede, Nadine; Lebbe, Celeste; Pages, Celine; Lesimple, Thierry; Dinulescu, Monica; Schellens, Jan H. M.; Leijen, Suzanne; Rottey, Sylvie; Kruse, Vibeke; Kefford, Richard; Faivre, Sandrine; Gomez-Roca, Carlos; Scheuler, Armin; Massimini, Giorgio; Raymond, Eric
errShare
errSave
Long-term Follow-up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients with Advanced Melanoma: KEYNOTE-029 Part 1B
err2020-10-01
err30
errOAAI
errCarlino, Matteo S.; Menzies, Alexander M.; Atkinson, Victoria; Cebon, Jonathan S.; Jameson, Michael B.; Fitzharris, Bernard M.; McNeil, Catriona M.; Hill, Andrew G.; Ribas, Antoni; Atkins, Michael B.; Thompson, John A.; Hwu, Wen-Jen; Hodi, F. Stephen; Guminski, Alexander D.; Kefford, Richard; Wu, Haiyan; Ibrahim, Nageatte; Moreno, Blanca Homet; Long, Georgina, V
errShare
errSave
Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors
err2020-08-03
err57
errOAAI
errLee, Jenny H.; Menzies, Alexander M.; Carlino, Matteo S.; McEvoy, Ashleigh C.; Sandhu, Shahneen; Weppler, Alison M.; Diefenbach, Russell J.; Dawson, Sarah-Jane; Kefford, Richard F.; Millward, Michael J.; Al-Ogaili, Zeyad; Tra, Thien; Gray, Elin S.; Wong, Stephen Q.; Scolyer, Richard A.; Long, Georgina, V; Rizos, Helen
errShare
errSave
Clinicians' attitudes and perceived barriers and facilitators to cancer treatment clinical practice guideline adherence: a systematic review of qualitative and quantitative literature
err2020-05-27
err63
errOAAI
errBierbaum, Mia; Rapport, Frances; Arnolda, Gaston; Easpaig, Brona Nic Giolla; Lamprell, Klay; Hutchinson, Karen; Delaney, Geoff P.; Liauw, Winston; Kefford, Richard; Olver, Ian; Braithwaite, Jeffrey
errShare
errSave
Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition
err2020-04-20
err6
errOAAI
errLee, Jenny H.; Shklovskaya, Elena; Lim, Su Yin; Carlino, Matteo S.; Menzies, Alexander M.; Stewart, Ashleigh; Pedersen, Bernadette; Irvine, Malama; Alavi, Sara; Yang, Jean Y. H.; Strbenac, Dario; Saw, Robyn P. M.; Thompson, John F.; Wilmott, James S.; Scolyer, Richard A.; Long, Georgina, V; Kefford, Richard F.; Rizos, Helen
errShare
errSave
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
err2020-01-01
err59
errOAAI
errHauschild, Axel; Ascierto, Paolo A.; Schadendorf, Dirk; Grob, Jean Jacques; Ribas, Antoni; Kiecker, Felix; Dutriaux, Caroline; Demidov, Lev V.; Lebbe, Celeste; Rutkowski, Piotr; Blank, Christian U.; Gutzmer, Ralf; Millward, Michael; Kefford, Richard; Haas, Tomas; D'Amelio, Anthony, Jr.; Gasal, Eduard; Mookerjee, Bijoyesh; Chapman, Paul B.
errShare
errSave
Associations of pigmentary and naevus phenotype with melanoma risk in two populations with comparable ancestry but contrasting levels of ambient sun exposure
err2019-06-07
err12
errOAAI
errCust, A. E.; Drummond, M.; Bishop, D. T.; Azizi, L.; Schmid, H.; Jenkins, M. A.; Hopper, J. L.; Armstrong, B. K.; Aitken, J. F.; Kefford, R. F.; Giles, G. G.; Demenais, F.; Goldstein, A. M.; Barrett, J. H.; Kanetsky, P. A.; Elder, D. E.; Mann, G. J.; Newton-Bishop, J. A.
errShare
errSave
Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients
err2019-05-01
err82
errOAAI
errLee, J. H.; Saw, R. P.; Thompson, J. F.; Lo, S.; Spillane, A. J.; Shannon, K. F.; Stretch, J. R.; Howle, J.; Menzies, A. M.; Carlino, M. S.; Kefford, R. F.; Long, G. V.; Scolyer, R. A.; Rizos, H.
errShare
errSave
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001
err2019-04-01
err669
errOAAI
errHamid, O.; Robert, C.; Daud, A.; Hodi, F. S.; Hwu, W. J.; Kefford, R.; Wolchok, J. D.; Hersey, P.; Joseph, R.; Weber, J. S.; Dronca, R.; Mitchell, T. C.; Patnaik, A.; Zarour, H. M.; Joshua, A. M.; Zhao, Q.; Jensen, E.; Ahsan, S.; Ibrahim, N.; Ribas, A.
errShare
errSave
Circulating Cytokines Predict Immune-Related Toxicity in Melanoma Patients Receiving Anti-PD-1-Based Immunotherapy
err2019-03-01
err282
errOAAI
errLim, Su Y.; Lee, Jenny H.; Gide, Tuba N.; Menzies, Alexander M.; Guminski, Alexander; Carlino, Matteo S.; Breen, Edmond J.; Yang, Jean Y. H.; Ghazanfar, Shila; Kefford, Richard F.; Scolyer, Richard A.; Long, Georgina V.; Rizos, Helen
errShare
errSave
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma
err2019-02-15
err51
errOAAI
errda Silva, Ines Pires; Wang, Kevin Y. X.; Wilmott, James S.; Holst, Jeff; Carlino, Matteo S.; Park, John J.; Quek, Camelia; Wongchenko, Matthew; Yan, Yibing; Mann, Graham; Johnson, Douglas B.; McQuade, Jennifer L.; Rai, Rajat; Kefford, Richard F.; Rizos, Helen; Scolyer, Richard A.; Yang, Jean Y. H.; Long, Georgina V.; Menzies, Alexander M.
errShare
errSave
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility
err2018-11-21
err37
errOAAI
errWilmott, James S.; Johansson, Peter A.; Newell, Felicity; Waddell, Nicola; Ferguson, Peter; Quek, Camelia; Patch, Ann-Marie; Nones, Katia; Shang, Ping; Pritchard, Antonia L.; Kazakoff, Stephen; Holmes, Oliver; Leonard, Conrad; Wood, Scott; Xu, Qinying; Saw, Robyn P. M.; Spillane, Andrew J.; Stretch, Jonathan R.; Shannon, Kerwin F.; Kefford, Richard F.; Menzies, Alexander M.; Long, Georgina V.; Thompson, John F.; Pearson, John V.; Mann, Graham J.; Hayward, Nicholas K.; Scolyer, Richard A.
errShare
errSave
Baseline Tumor Size Is an Independent Prognostic Factor for Overall Survival in Patients with Melanoma Treated with Pembrolizumab
err2018-10-15
err222
errOAAI
errJoseph, Richard W.; Elassaiss-Schaap, Jeroen; Kefford, Richard; Hwu, Wen-Jen; Wolchok, Jedd D.; Joshua, Anthony M.; Ribas, Antoni; Hodi, F. Stephen; Hamid, Omid; Robert, Caroline; Daud, Adil; Dronca, Roxana; Hersey, Peter; Weber, Jeffrey S.; Patnaik, Amita; de Alwis, Dinesh P.; Perrone, Andrea; Zhang, Jin; Kang, S. Peter; Ebbinghaus, Scot; Anderson, Keaven M.; Gangadhar, Tara C.
errShare
errSave
Efficacy of novel immunotherapy regimens in patients with metastatic melanoma with germline CDKN2A mutations
err2018-10-05
err37
errOAAI
errHelgadottir, Hildur; Ghiorzo, Paola; van Doorn, Remco; Puig, Susana; Levin, Max; Kefford, Richard; Lauss, Martin; Queirolo, Paola; Pastorino, Lorenza; Kapiteijn, Ellen; Potrony, Miriam; Carrera, Cristina; Olsson, Hakan; Hoiom, Veronica; Jonsson, Goran
errShare
errSave
Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma
err2018-09-20
err82
errOAAI
errIrvine, Mal; Stewart, Ashleigh; Pedersen, Bernadette; Boyd, Suzanah; Kefford, Richard; Rizos, Helen
errShare
errSave